Search
for
Sort by
Research 211–240 of 1000+
- Gender differences in skin: A review of the literature
- Adult polycystic ovary syndrome begins in childhood
- Nanoparticles in wound healing from hope to promise from promise to routine
- COVID‐19, androgens, and androgenic alopecia
- Polycystic Ovarian Disease (PCOD): Epidemiological Perspectives and Preventive Strategies through Healthy Lifestyle and Alternative Approaches
- Polycystic Ovary Syndrome in Adolescents
- Complications in Esthetic Surgery
- Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Analysis of lncRNAs Expression Profiles in Hair Follicle of Hu Sheep Lambskin
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Influence of sex and functional status on the value of serum steroid profiling in discriminating adrenocortical carcinoma from adrenocortical adenoma
- Character, Genre, and Ethos in Nineteenth-Century British Drama
- Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- Current evaluation of amenorrhea
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- The therapeutic use of androgens in women
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- Current Status of Fractional Laser Resurfacing
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- Melatonin promotes Cashmere goat (<i>Capra hircus</i>) secondary hair follicle growth: a view from integrated analysis of long non-coding and coding RNAs